World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
32644
World Ranking
17834
National Ranking
8898

Thomas P. Miller publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Thomas P. Miller sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 224 publications — 5th percentile

5% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Thomas P. Miller D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas P. Miller sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 78 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Thomas P. Miller is affiliated with the University of Arizona in the United States. Their research focuses primarily on the fields of Biochemistry, Genetics and Molecular Biology, as well as Agricultural and Biological Sciences.

The scientist's work encompasses several specialized subfields including Molecular Biology, Plant Science, and Cell Biology. Their research topics cover a range of areas such as Powdery Mildew Fungal Diseases, Plant Pathogens and Fungal Diseases, Plant Pathogens and Resistance, RNA and protein synthesis mechanisms, Molecular Biology Techniques and Applications, and RNA modifications and cancer.

Thomas P. Miller has contributed to multiple scientific publications. Notable recent papers include:

  • First Report of Phyllactinia chubutiana Causing Powdery Mildew on Goji Berry Plants (Lycium barbarum and L. chinense) in the United States, published in 2023 in Plant Disease
  • Simultaneous mapping of RNA secondary, tertiary, and quaternary structure in living cells by multi-site DMS probing, published in 2024 in bioRxiv (Cold Spring Harbor Laboratory)

Frequent coauthors who have collaborated with Thomas P. Miller in recent work include:

  • Karina Elfar
  • Marcelo I. Bustamante
  • S. Rooney-Latham
  • Akif Eskalen
  • Irfana Saleem

The publications of Thomas P. Miller have appeared in venues such as Plant Disease and bioRxiv (Cold Spring Harbor Laboratory).

Best Publications

  • The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

    Andreas Rosenwald;George Wright;Wing C. Chan;Wing C. Chan;Joseph M. Connors

  • Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma

    Richard I. Fisher;Ellen R. Gaynor;Steve Dahlberg;Martin M. Oken

  • Stromal gene signatures in large-B-cell lymphomas

    G Lenz;G Wright;S S Dave;W Xiao

  • Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells

    Sandeep S. Dave;George Wright;Bruce Tan;Andreas Rosenwald;Andreas Rosenwald

  • Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

    Andreas Rosenwald;George Wright;Karen Leroy;Xin-You Yu

  • Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma

    Thomas P. Miller;Steve Dahlberg;J. Robert Cassady;David J. Adelstein

  • The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

    Andreas Rosenwald;George Wright;Adrian Wiestner;Wing C. Chan;Wing C. Chan

  • Molecular diagnosis of Burkitt's lymphoma.

    Sandeep S. Dave;Kai Fu;George W. Wright;Lloyd T. Lam

  • Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

    W. S. Dalton;T. M. Grogan;P. S. Meltzer;R. J. Scheper

  • Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience.

    D O Dixon;B Neilan;S E Jones;D A Lipschitz

  • P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil.

    Thomas P. Miller;Thomas M. Grogan;William S. Dalton;Catherine M. Spier

  • New Treatment Options Have Changed the Survival of Patients With Follicular Lymphoma

    Richard I. Fisher;Michael LeBlanc;Oliver W. Press;David G. Maloney

  • Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project.

    Lisa M. Rimsza;Robin A. Roberts;Thomas P. Miller;Joseph M. Unger

  • Phase II Trial of CHOP Chemotherapy Followed by Tositumomab/Iodine I-131 Tositumomab for Previously Untreated Follicular Non-Hodgkin's Lymphoma: Five-Year Follow-Up of Southwest Oncology Group Protocol S9911

    Oliver W. Press;Joseph M. Unger;Rita M. Braziel;David G. Maloney

  • Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma

    Patrick J. Stiff;Joseph M. Unger;James R. Cook;Louis S. Constine

  • Utility of Fine-Needle Aspiration As a Diagnostic Technique in Lymphoma

    Sean T. Hehn;Thomas M. Grogan;Thomas P. Miller

  • Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: A prospective Southwest Oncology Group trial

    TP Miller;TM Grogan;S Dahlberg;CM Spier

  • Phase II Study of Rituximab Plus Three Cycles of CHOP and Involved-Field Radiotherapy for Patients With Limited-Stage Aggressive B-Cell Lymphoma: Southwest Oncology Group Study 0014

    Daniel O. Persky;Joseph M. Unger;Catherine M. Spier;Baldassarre Stea

  • Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications.

    Yolanda Fernández;Monique Verhaegen;Thomas P. Miller;Jenny L. Rush

  • Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67

    Thomas M. Grogan;Scott M. Lippman;Catherine M. Spier;Donald J. Slymen

Frequent Co-Authors

Richard I. Fisher
Richard I. Fisher Fox Chase Cancer Center
Thomas M. Grogan
Thomas M. Grogan Roche (Switzerland)
Lisa M. Rimsza
Lisa M. Rimsza Mayo Clinic
Jonathan W. Friedberg
Jonathan W. Friedberg University of Rochester
Oliver W. Press
Oliver W. Press University of Washington
Elias Campo
Elias Campo University of Barcelona
Louis M. Staudt
Louis M. Staudt National Institutes of Health
Randy D. Gascoyne
Randy D. Gascoyne BC Cancer Agency
David G. Maloney
David G. Maloney Fred Hutchinson Cancer Research Center
Elaine S. Jaffe
Elaine S. Jaffe National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in healthcare doesn’t always mean going to medical school. Many students explore alternative routes, such as nursing, which also offer strong job prospects and flexible study options. Online programs have become increasingly popular for their convenience and affordability.

For working nurses aiming to advance, online nursing phd programs provide an accessible way to move into research or academic roles. If you’re looking to become a registered nurse, exploring the cheapest online bsn programs can help you earn your degree without the heavy financial burden.

Non-nurses who want to switch into nursing may benefit from the cheapest direct entry msn programs, designed for those holding a bachelor’s in another field. For applicants seeking less competitive entry, it’s useful to know what is the easiest nursing school to get into to jumpstart their healthcare career.

Exploring these alternative online pathways can open multiple doors in medicine and healthcare, catering to a wide range of backgrounds and career goals.

Best Scientists Citing Thomas P. Miller

Trending Scientists

Recently Published Articles